Literature DB >> 9283056

A survey of clinician attitudes and management practices in hypertension.

F A McAlister1, A Laupacis, K K Teo, P G Hamilton, T J Montague.   

Abstract

In order to determine the compliance of Canadian physicians with evidence-based hypertension guidelines, a self-administered questionnaire survey was distributed to a stratified random sample of 473 physicians in Central Alberta, Canada in December 1995. Excluding non-deliverable questionnaires, a response rate of 67% was obtained. Twenty-five per cent of respondents routinely used the fourth Korotkoff sound to define diastolic blood pressure (DBP). Investigations recommended for the initial workup of a patient with mild hypertension included serum creatinine (90%), electrolytes (72%), glucose (50%), cholesterol (44%), electrocardiogram (65%), and urinalysis (76%). The non-pharmacologic treatment advice routinely advocated for patients with mild hypertension included salt restriction (87%), weight loss (100%), and regular aerobic exercise (92%). While 46% of respondents recommended antihypertensive therapy for an otherwise healthy patient with an average DBP of 95 mm Hg, 76% recommended therapy for patients with the same BP plus target organ damage or other cardiovascular risk factors. Medication choices varied, although angiotensin-converting enzyme inhibitors were chosen by 46% for patients with uncomplicated essential hypertension and 67% for patients with other cardiovascular risk factors, and beta-blockers were the most frequently chosen first-line agents (56%) for the patient with target organ damage. There was considerable variability in the self-reported practice patterns, and concordance was greater for those recommendations which were consistent across the currently available guidelines. Consistent with the principle underlying all of the current hypertension guidelines, respondents were more aggressive in their treatment of hypertensive patients with other cardiovascular risk factors or target organ damage.

Entities:  

Mesh:

Year:  1997        PMID: 9283056     DOI: 10.1038/sj.jhh.1000457

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  8 in total

1.  New Canadian hypertension recommendations. So what?

Authors:  N R Campbell
Journal:  Can Fam Physician       Date:  2000-07       Impact factor: 3.275

Review 2.  The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future.

Authors:  F A McAlister; N R Campbell; K Zarnke; M Levine; I D Graham
Journal:  CMAJ       Date:  2001-02-20       Impact factor: 8.262

3.  Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades.

Authors:  Finlay A McAlister; Kathryn Wilkins; Michel Joffres; Frans H H Leenen; George Fodor; Marianne Gee; Mark S Tremblay; Robin Walker; Helen Johansen; Norm Campbell
Journal:  CMAJ       Date:  2011-05-16       Impact factor: 8.262

4.  When should hypertension be treated? The different perspectives of Canadian family physicians and patients.

Authors:  F A McAlister; A M O'Connor; G Wells; S A Grover; A Laupacis
Journal:  CMAJ       Date:  2000-08-22       Impact factor: 8.262

5.  Predictors of patients' preferences for treatments to prevent heart disease.

Authors:  T Marshall; S Bryan; P Gill; S Greenfield; K Gutridge
Journal:  Heart       Date:  2006-05-18       Impact factor: 5.994

6.  Management of hypertension in elderly long-term care residents.

Authors:  Ross T Tsuyuki; Donna L McLean; Finlay A McAlister
Journal:  Can J Cardiol       Date:  2008-12       Impact factor: 5.223

7.  Patient and general practitioner attitudes to taking medication to prevent cardiovascular disease after receiving detailed information on risks and benefits of treatment: a qualitative study.

Authors:  Nicola K Gale; Sheila Greenfield; Paramjit Gill; Kerry Gutridge; Tom Marshall
Journal:  BMC Fam Pract       Date:  2011-06-26       Impact factor: 2.497

8.  How often are ineffective interventions still used in clinical practice? A cross-sectional survey of 6,272 clinicians in China.

Authors:  Xiao-Min Luo; Jin-Ling Tang; Yong-Hua Hu; Li-Ming Li; Yan-Ling Wang; Wei-Zhong Wang; Li Yang; Xiao-hui Ouyang; Guang-cai Duan
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.